110 related articles for article (PubMed ID: 10227655)
1. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy.
Riggs JE
Neurology; 1999 Apr; 52(7):1517-8. PubMed ID: 10227655
[No Abstract] [Full Text] [Related]
2. Recombinant human nerve growth factor and diabetic polyneuropathy.
Zochodne DW; Said G
Neurology; 1998 Sep; 51(3):662-3. PubMed ID: 9748004
[No Abstract] [Full Text] [Related]
3. Nerve growth factor in diabetic neuropathy.
Anand P
Lancet; 1998 Nov; 352(9140):1629-30. PubMed ID: 9843133
[No Abstract] [Full Text] [Related]
4. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group.
Apfel SC; Kessler JA; Adornato BT; Litchy WJ; Sanders C; Rask CA
Neurology; 1998 Sep; 51(3):695-702. PubMed ID: 9748012
[TBL] [Abstract][Full Text] [Related]
5. Nerve growth factor (NGF) may hold promise in treatment of peripheral neuropathy.
AIDS Patient Care STDS; 1997 Jun; 11(3):197. PubMed ID: 11361801
[No Abstract] [Full Text] [Related]
6. Nerve growth factor promising in diabetic neuropathy...and in HIV-1-related neuropathy.
Larkin M
Lancet; 1998 Sep; 352(9133):1039. PubMed ID: 9759757
[No Abstract] [Full Text] [Related]
7. Nerve growth factor and diabetic neuropathy.
Dyck PJ
Lancet; 1996 Oct; 348(9034):1044-5. PubMed ID: 8874450
[No Abstract] [Full Text] [Related]
8. Biological actions of nerve growth factor in the peripheral nervous system.
Rask CA
Eur Neurol; 1999; 41 Suppl 1():14-9. PubMed ID: 10023124
[TBL] [Abstract][Full Text] [Related]
9. Neurotrophic factors and diabetic peripheral neuropathy.
Apfel SC
Eur Neurol; 1999; 41 Suppl 1():27-34. PubMed ID: 10023126
[TBL] [Abstract][Full Text] [Related]
10. Human studies of recombinant human nerve growth factor and diabetic peripheral neuropathy.
Freeman R
Eur Neurol; 1999; 41 Suppl 1():20-6. PubMed ID: 10023125
[TBL] [Abstract][Full Text] [Related]
11. Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?
Apfel SC
Int Rev Neurobiol; 2002; 50():393-413. PubMed ID: 12198818
[TBL] [Abstract][Full Text] [Related]
12. Emerging opportunities in peripheral neuropathy. Preface.
Said G; Bril V
Eur Neurol; 1999; 41 Suppl 1():1-2. PubMed ID: 10223842
[No Abstract] [Full Text] [Related]
13. Growth factors and diabetic neuropathy.
Thomas PK
Diabet Med; 1994 Oct; 11(8):732-9. PubMed ID: 7851066
[TBL] [Abstract][Full Text] [Related]
14. [Diabetic neuropathy: clinical and experimental progress in its pathogenesis and treatment].
Maeda K; Yasuda H
Nihon Rinsho; 1999 Mar; 57(3):578-83. PubMed ID: 10199137
[TBL] [Abstract][Full Text] [Related]
15. [Nerve growth factor and diabetic neuropathy].
Castellano O; Martínez-Martí L; Gómez-Fernández L
Rev Neurol; 1998 Jun; 26(154):1032-9. PubMed ID: 9658489
[TBL] [Abstract][Full Text] [Related]
16. Nerve growth factor study opens.
GMHC Treat Issues; 1996 Nov; 10(11):9. PubMed ID: 11364013
[TBL] [Abstract][Full Text] [Related]
17. Neurotrophins and other growth factors in diabetic neuropathy.
Zochodne DW
Semin Neurol; 1996 Jun; 16(2):153-61. PubMed ID: 8987129
[TBL] [Abstract][Full Text] [Related]
18. Neurotrophic factors in diabetic neuropathy.
Crain SM
Trends Neurosci; 1995 Jan; 18(1):15-6. PubMed ID: 7535484
[No Abstract] [Full Text] [Related]
19. Insulin-like growth factor replacement therapy for diabetic neuropathy: experimental basis.
Ishii DN; Lupien SB
Exp Diabesity Res; 2003; 4(4):257-69. PubMed ID: 14668048
[No Abstract] [Full Text] [Related]
20. [Nerve growth factor (NGF): pathophysiologic importance and possible therapeutic consequences].
Hellweg R
Nervenarzt; 1992 Jan; 63(1):52-6. PubMed ID: 1570042
[No Abstract] [Full Text] [Related]
[Next] [New Search]
